VivoSeq
Cardiovascular

Cardiac Dysfunction

1

Pipeline Programs↗

1

Active Trials↗

0

Companies Involved↗

Cardiac Dysfunction is an early-stage landscape with 1 program across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

Preclinical1

Prevention Therapy

National Cheng-Kung University Hospital

Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved
No programs

Analysis

Trial Status

7

clinical trials

Unknown status3 · 43%
Completed3 · 43%
Not yet recruiting1 · 14%

Clinical Trials

Trial Activity

7 trials

Cancer Therapy-related Cardiac Dysfunction Occuring in Children Treated by Anticancer Drugs for Malignancies
Not yet recruiting·UUniversity Hospital, Caen·N/A·NCT05602103·10,000 enrolled
Molecular Mechanisms of Volume Overload-Aim 1(SCCOR in Cardiac Dysfunction and Disease)
Completed·UUniversity of Alabama at Birmingham·Phase 2/3·NCT01052428·38 enrolled
Pre-clinical Cardiac Dysfunction Among Asymptomatic Hypertensive Patients
Completed·WWayne State University·N/A·NCT00689819·123 enrolled
Identification of Anticancer Drugs Associated With Cancer Therapy-related Cardiac Dysfunction: a Pharmacovigilance Study
Completed·UUniversity Hospital, Caen·N/A·NCT06268535·36,580,288 enrolled
CAR-T Cell Induced Cardiac Dysfunction: A Prospective Study
Unknown status·FFondazione Policlinico Universitario Agostino Gemelli IRCCS·N/A·NCT06106776·48 enrolled
Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction
Unknown status·NNational Cheng-Kung University Hospital·N/A·NCT05892146·100 enrolled
Detecting and Treating Subclinical Anthracycline Therapy Related Cardiac Dysfunction in Low Income Country.
Unknown status·MMakerere University·Phase 3·NCT03542058·50 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)